Clinical Trial Update: Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of rhTPO and eltrombopag in patients with primary immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Primary Immune Thrombocytopenia | Phase 4 | Status: UNKNOWN